WinstonWınston
Marpai logo

Marpai

MRAI
Medical - Healthcare Plans · Healthcare
Price
$1.65
+0.21 (+14.58%)
Market Cap
$32.7M
Winston Score
Winston looking sleepy
No score yet — Winston is napping.
We couldn’t gather enough financial data to score this stock reliably.

Share count rising — dilution

+242.2% over 4y

The company has issued more shares over this period, which dilutes each existing shareholder’s stake.

Diluted shares outstanding: 5.1M (2021) → 17.4M (2025)

Marpai is a small health insurance company that uses artificial intelligence to manage health benefits for employers. Instead of offering traditional insurance, it acts as a third-party administrator, helping self-funded employers — meaning companies that pay their workers' medical claims directly — manage those costs more efficiently. It operates mainly in the United States and targets small to mid-sized businesses looking for a cheaper alternative to standard group health insurance.

Marpai earns money by charging employers fees to administer their health plans, rather than collecting insurance premiums. The company is very small, with a market cap near zero, and it has been losing significantly more money than it earns, reflected in its deeply negative operating margin. The main growth driver is convincing more employers to switch to self-funded health plans managed by AI-driven tools, but the primary risk is that the company burns through cash faster than it can grow its customer base, raising real questions about its long-term financial survival.

Winston Score History

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

-39.5% YoY

YoY Growth Rate

Revenue declining

EPS Growth

-213.3% YoY

YoY Growth Rate

Earnings declining

R&D Spend

$7,000/ year

Declining (-76% vs prior year)

0.0% of revenue

Below sector average (18%)

R&D spend declining — could signal cost-cutting or efficiency

Insider Activity

82.3%ownership

Flat

Insiders holding steady — not selling despite ability to

Cash Runway

~0 months

$133,000 cash & investments

Quarterly Free Cash Flow

Short runway — potential dilution ahead through share issuance

Cash watch

Marpai has less than a year of cash at its current burn rate. Growth investors should watch for potential share dilution from future fundraising — that directly reduces your ownership.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin
24.2%
Thin — 24.2% gross margin
Operating Margin
-123.0%
Losing money on operations — -123.0%
ROCE
N/A
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY
-35.8%
Shrinking sales (-35.8% YoY)
EPS YoY
N/A
Data not available
EPS Consistency
0/8 quarters
Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion
N/A
Data not available
FCF Margin
-41.2%
Burning cash (-41.2%)

Free cash flow is negative. They are burning cash, not generating it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity
N/A
Data not available
Interest Cover
N/A
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)
N/M
Negative earnings — P/E not meaningful
P/E vs Forward
N/A
not available
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial